Literature DB >> 12775065

Selective remediation of contaminated sites using a two-level multiphase strategy and geostatistics.

Hirotaka Saito1, Pierre Goovaerts.   

Abstract

Selective soil remediation aims to reduce costs by cleaning only the fraction of an exposure unit (EU) necessary to lower the average concentration below the regulatory threshold. This approach requires a prior stratification of each EU into smaller remediation units (RU) which are then selected according to various criteria. This paper presents a geostatistical framework to account for uncertainties attached to both RU and EU average concentrations in selective remediation. The selection of RUs is based on their impact on the postremediation probability for the EU average concentration to exceed the regulatory threshold, which is assessed using geostatistical stochastic simulation. Application of the technique to a set of 600 dioxin concentrations collected at Piazza Road EPA Superfund site in Missouri shows a substantial decrease in the number of RU remediated compared with single phase remediation. The lower remediation costs achieved by the new strategy are obtained to the detriment of a higher risk of false negatives, yet for this data set this risk remains below the 5% rate set by EPA region 7.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12775065     DOI: 10.1021/es020737j

Source DB:  PubMed          Journal:  Environ Sci Technol        ISSN: 0013-936X            Impact factor:   9.028


  2 in total

1.  Geostatistical modeling of the spatial distribution of soil dioxin in the vicinity of an incinerator. 2. Verification and calibration study.

Authors:  Pierre Goovaerts; Hoa T Trinh; Avery H Demond; Timothy Towey; Shu-Chi Chang; Danielle Gwinn; Biling Hong; Alfred Franzblau; David Garabrant; Brenda W Gillespie; James Lepkowski; Peter Adriaens
Journal:  Environ Sci Technol       Date:  2008-05-15       Impact factor: 9.028

2.  Geostatistics and GIS: tools for characterizing environmental contamination.

Authors:  Shannon L Henshaw; Frank C Curriero; Timothy M Shields; Gregory E Glass; Paul T Strickland; Patrick N Breysse
Journal:  J Med Syst       Date:  2004-08       Impact factor: 4.460

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.